Critical Care Flashcards
CO2 acid or base controlled by what
Acid lungs
Integrillin dose for renal impairment
CrCl <50 1mg/kg/min
Milrinone MOA
inhibit PDE which normally degrades cAMP into inactive peptides
Propofol special consideration
10% lipid emulsion so has 1.1 kcal/mL
Cardiogenic shock tx
Cold/wet= inotrope + diuretic
Cold/dry= inotrope +/- fluid
Septic shock tx
Fluids -30mL/kg of crystalloid
pressors if hypotension
-NE
empiric antimicrobial
Which NMBA are non-depolarizing agents
Amine Structure
- Atracurium
- Cisatracurium
Steroidal Structure
- Pancuronium
- Rocuronium
- Vecuronium
Cangrelor to Prasugrel
Cangrelor 30mcg/kg bolus then 4 mcg/kg/min infusion Prasugrel 60mg immediately
Dexmedetomidine special considerations
does not cause respiratory depression for <24 hours in ICU
PCI treatment
UFH, LMWH, or Bivalirudin ASA 325mg x1 LD os P2Y12 Stent placement +/- GP 2b/3a
sepsis Gram - bacteria
S. aureus S. pneumoniae
pH <7.35 is what type of hemodynamic problem
acidosis
SAH tx
BP control -SBP <140 Vasospasm control -Nimodipine
Preload in left side of heart is what
PCWP
Obstructive shock hemodynamic parameters
CO ↓
ADHF when to hold ivabradine
Cardiogenic shock symptomatic ↓HR, BP new AFib
H’s and t’s 5, 4
H
- hypoxia
- hypovolemia
- H ion
- hypo/hyperkalemia
- hypotermia
T
- toxin
- tamponade
- tension pneumothorax
- thombosis
ADHF when to hold ACEi/ARB/ARNi
cardiogenic shock symptomatic ↓ BP AKI ↑K
ADHF Cold &wet tx
SBP <90 w/ symptoms
-Inotrope + diuretics
if no symptoms
-IV diuretics +/- vasodilators
Arterial Line measures what
blood gas BP continuously
AIS BP goals
received tPA <180/<105
no tPA or thrombectomy <220/<120
No tPA with thrombectomy SBP <160
Hemorrhagic converson SBP <160
Sepsis 3 definition
> 2 qSOFA –for ED/Floor pt SOFA –ICU patients >2 pts
Define metabolic alkalosis
pH >7.45 HCO3 >26
PRIS s/s 3
ARF cardiac arrest dyslipidemia
Anion gap formula
Na - (HCO3 + Cl) normal <12
Angiotensin 2 Action
Vasoconstriction ↑ SVR
ADHF “cold” symptoms 8
fatigue
early satiety, nausea, anorexia
altered mental status
cool extremeties
tachycardia
narrow pulse pressure
sympomatic hypotension
↓Na
Dexmedetomidine ADE 5
↓ BP ↓ HR HTN N/V heart Block
Pancuronium ADE 2
tachycardia HTN
Thromboembolic prophylaxis LMWH dose
40mg SQ q24h 30mg SQ q12h if high risk
ADHF warm & wet tx
IV loop diuretic
naive–furosemide 40
experienced–2-2.5x home dose
+ HCTZ, metolazone, chlorothiazide
+/- vasodilators
Metabolic acidosis etiology
Anion gap
-MUDPILES –methanol, uremia, Diabetic ketoacidosis, propylene glycol, isoniazid and iron, lactic acid, ehtylene glycol, salicylates
Non-anion gap
-ACCRUED –Aldosterone inhibitors, compensation, carbonic anhydrase inhibitors, renal tubular acidosis, ureteral diversion, extraailmentation, diarrhea
pH ___ as HCO3___ pH ___ as PaCO2___
increases, increases decreases, increases
ADHF when to hold BB
cardiogenic shock symptomatic ↓BP, HR
Andexanet alfa MOA
decoy protein that sequesters and prevents binding to endogenous factor 10a
Activated 4-factor product
Feiba
Kcentra MOA
PCC 4 factor, unactivated replaces factors 2,9,10, and unactivated 7
Vecuronium Contraindication 2
Renal failure Liver failure
Ketamine MOA
NMDA blocker ACh blocker L-type Ca block
Vasopressors ADE
HTN tissue necrosis ARF Ischemia
Dopamine 1 & 2 action
Vasodilation ↑ UOP ↓ SVR
What happens when you add acid to buffer system
combine with HCO3 generating CO2 that is dissolved in the blood and subsequently eliminated via the lungs
4-factor product
Kcentra
Sepsis Gram + bacteria
E. coli Klebsiella spp. Pseudomonas
Phenylephrine Selectivity and action
Alpha 1 & 2 vasoconstriction
Alpha 1 Action
Vasocontriction ↑SVR ↑MAP
Initial resuscitation of Shock
“VIP” Ventilate Infuse Pump 30mL/kg IV crystalloid in 1st 3hrs MAP >65 normalize lactate
Which drug is a venous vasodilator
Nitroglycerin
pH normal value
7.35-7.45
Compensation for respiratory alkalosis
Acute
-for each ↓10 of PaCO2 HCO3 ↓ 2mEq/L
Chronic
-for each ↓10 of PaCO2 HCO3 ↓5 mEq/L
Beta 2 action
Vasodilation Bronchodilation ↓SVR
Norepinephrine Selectivity and Action
Alpha 1 > beta 1 > Beta 2 ↑ Chronotropy/Inotropy Vasoconstriction
Respiratory Alkalosis etiology
Central stimulation hypoxia latrogenic
Vecuronium ADE 2
Bradycardia Prolonged blockade on D/C
Beta 1 action
Chronotropy Inotropy Vasodilation ↑CO ↑HR ↓SVR
Distributive shock hemodynamic parameters
SVT ↓
Milrinone Hemodynamic effect HR, MAP, CO, SVR
HR ↑ MAP ↓ CO ↑ SVR ↓
Hemorrhagic shock treatment
identify source of bleeding volume rsuscitate –crystalloids –Packe red blood cells Vasopressors to MAP >60
Cardiogenic Shock hemodynamic parameters
CO ↓
TX of hyperkalemia
Ca gluconate
regular insulin
albuterol
sodium bicarb
furosemide
Na polystyrene sulfonate
Suggammadex MOA
modified cyclodextrin that encapsulates rocuronium and vecuronium to inhibit their binding to ACh receptor
Propofol MOA
GABA receptor